An Integrated Understanding of the Molecular Mechanisms of How Adipose Tissue Metabolism Affects Long-term Body Weight Maintenance.
Knut MaiLinna LiSusanna WiegandMaria BrachsVerena LeupeltAndrea ErnertPeter KühnenNorbert HübnerPeter RobinsonWei ChenHeiko KrudeJoachim SprangerPublished in: Diabetes (2018)
Lifestyle-based weight loss interventions frequently demonstrate long-term inefficiency and weight regain. Identification of underlying mechanisms and predictors to identify subjects who will benefit from lifestyle-based weight loss strategies is urgently required. We analyzed 143 adults of the randomized Maintain trial (Maintain-Adults) after intended weight loss to identify mechanisms contributing to the regulation of body weight maintenance. Unbiased RNA sequencing of adipose and skeletal muscle biopsies revealed fatty acid metabolism as a key pathway modified by weight loss. Variability of key enzymes of this pathway, estimates of substrate oxidation, and specific serum acylcarnitine (AC) species, representing a systemic snapshot of in vivo substrate flux, predicted body weight maintenance (defined as continuous or dichotomized [< or ≥3% weight regain] variable) 18 months after intended weight loss in the entire cohort. Key results were confirmed in a similar randomized controlled trial in 137 children and adolescents (Maintain-Children), which investigated the same paradigm in a pediatric cohort. These data suggest that adaption of lipid utilization in response to negative energy balance contributes to subsequent weight maintenance. Particularly a functional role for circulating ACs, which have been suggested to reflect intracellular substrate utilization, as mediators between peripheral energy stores and control of long-term energy homeostasis was indicated.
Keyphrases
- weight loss
- body weight
- gastric bypass
- bariatric surgery
- roux en y gastric bypass
- adipose tissue
- randomized controlled trial
- skeletal muscle
- fatty acid
- insulin resistance
- study protocol
- weight gain
- glycemic control
- phase iii
- physical activity
- single cell
- phase ii
- acute coronary syndrome
- open label
- type diabetes
- obese patients
- clinical trial
- metabolic syndrome
- double blind
- hydrogen peroxide
- machine learning
- big data
- amino acid
- high resolution
- placebo controlled
- mass spectrometry